We conducted a survey among Italian HIV specialists to study the utilization of statins and aspirin, administering a questionnaire aimed at investigating their use, the use of guidelines and scores, and the management of interactions. The answers were uniform in the different geographic areas. The majority directly prescribe statins and 43% of them prescribe aspirin. The majority follows guidelines and utilize scores to calculate the CV risk. Our survey demonstrates the commitment and autonomy in prescribing statins and aspirin of Italian physicians. There is a rationale to generate guidelines to overcome the differences and limitations among current recommendations.
Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients : a survey among Italian HIV physicians / P. Maggi, G.V. De Socio, S. Cicalini, M. D'Abbraccio, G. Dettorre, A. Di Biagio, C. Martinelli, G. Nunnari, S. Rusconi, L. Sighinolfi, V. Spagnuolo, N. Squillace. - In: NEW MICROBIOLOGICA. - ISSN 1121-7138. - 40:2(2017 Apr), pp. 139-142.
Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients : a survey among Italian HIV physicians
S. Rusconi;
2017
Abstract
We conducted a survey among Italian HIV specialists to study the utilization of statins and aspirin, administering a questionnaire aimed at investigating their use, the use of guidelines and scores, and the management of interactions. The answers were uniform in the different geographic areas. The majority directly prescribe statins and 43% of them prescribe aspirin. The majority follows guidelines and utilize scores to calculate the CV risk. Our survey demonstrates the commitment and autonomy in prescribing statins and aspirin of Italian physicians. There is a rationale to generate guidelines to overcome the differences and limitations among current recommendations.| File | Dimensione | Formato | |
|---|---|---|---|
|
Survey statine-aspirina, New Microbiologica 2017.pdf
accesso riservato
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
442.75 kB
Formato
Adobe PDF
|
442.75 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
139.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
439.18 kB
Formato
Adobe PDF
|
439.18 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




